Ultragenyx Pharmaceutical Inc. and Mereo Biopharma Group plc, along with investors, had hoped for an...
Ultragenyx and partner Mereo BioPharma’s brittle bone disease trial will continue. Investors had wan...
Analysts are keeping the faith in Ultragenyx’s brittle bone disease medicines despite the monoclonal...
Ultragenyx Pharmaceutical and Mereo BioPharma shares tumble as investors await key phase III UX143 o...